Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 25, 2024

BUY
$151.44 - $200.09 $1,817 - $2,401
12 Added 0.63%
1,925 $379,000
Q3 2023

Oct 27, 2023

SELL
$167.14 - $192.77 $56,660 - $65,349
-339 Reduced 15.05%
1,913 $332,000
Q2 2023

Aug 11, 2023

SELL
$160.94 - $186.23 $2,575 - $2,979
-16 Reduced 0.71%
2,252 $387,000
Q1 2023

May 15, 2023

BUY
$145.48 - $175.02 $87,142 - $104,836
599 Added 35.89%
2,268 $377,000
Q4 2022

Feb 13, 2023

SELL
$131.14 - $157.47 $115,796 - $139,046
-883 Reduced 34.6%
1,669 $244,000
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $24,764 - $30,485
167 Added 7.0%
2,552 $378,000
Q2 2022

Aug 15, 2022

BUY
$155.97 - $200.09 $4,367 - $5,602
28 Added 1.19%
2,385 $410,000
Q1 2022

May 16, 2022

BUY
$181.39 - $234.03 $31,017 - $40,019
171 Added 7.82%
2,357 $445,000
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $20,337 - $25,938
105 Added 5.05%
2,186 $533,000
Q3 2021

Nov 15, 2021

BUY
$189.29 - $209.69 $12,114 - $13,420
64 Added 3.17%
2,081 $404,000
Q2 2021

Aug 16, 2021

BUY
$155.9 - $187.99 $65,322 - $78,767
419 Added 26.22%
2,017 $376,000
Q1 2021

May 17, 2021

BUY
$144.0 - $169.39 $230,112 - $270,685
1,598 New
1,598 $252,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.3B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Bsw Wealth Partners Portfolio

Follow Bsw Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bsw Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Bsw Wealth Partners with notifications on news.